BONORA, BENEDETTA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.077
EU - Europa 456
AS - Asia 435
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
OC - Oceania 2
SA - Sud America 1
Totale 3.977
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.068
IT - Italia 225
CN - Cina 212
SG - Singapore 153
SE - Svezia 50
FI - Finlandia 40
FR - Francia 38
DE - Germania 31
GB - Regno Unito 25
IN - India 22
VN - Vietnam 18
IE - Irlanda 13
KR - Corea 8
UA - Ucraina 7
CA - Canada 6
NL - Olanda 5
AT - Austria 4
EU - Europa 4
HK - Hong Kong 4
TR - Turchia 4
CH - Svizzera 3
JP - Giappone 3
MK - Macedonia 3
MX - Messico 3
TH - Thailandia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
DK - Danimarca 2
EG - Egitto 2
ES - Italia 2
PT - Portogallo 2
SA - Arabia Saudita 2
AU - Australia 1
BR - Brasile 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.977
Salva come PNG Salva come JPEG
Città #
Fairfield 555
Chandler 334
Woodbridge 249
Houston 225
Cambridge 205
Ashburn 193
Seattle 183
Ann Arbor 149
Wilmington 145
Singapore 128
Santa Clara 85
San Diego 84
Boardman 69
Medford 49
Princeton 49
Padova 42
Roxbury 42
Beijing 37
Des Moines 35
New York 34
Helsinki 28
Milan 23
Dong Ket 18
Dearborn 17
Guangzhou 16
Nanjing 13
Shanghai 13
Jacksonville 12
Redmond 12
Shenyang 12
Dublin 11
Paris 8
Rome 8
Hebei 7
Selvazzano Dentro 7
Sommacampagna 7
Hefei 6
Kunming 6
Nanchang 6
Pune 6
Breganze 5
London 5
Los Angeles 5
Redwood City 5
Vicenza 5
Bologna 4
Dallas 4
Guiglia 4
Hangzhou 4
Jinan 4
Naples 4
New Delhi 4
Ningbo 4
Nuremberg 4
Ogden 4
Oristano 4
Rockville 4
Tianjin 4
Auburn Hills 3
Bari 3
Boston 3
Cerveteri 3
Changsha 3
Hyderabad 3
Istanbul 3
Munich 3
Pravisdomini 3
Santa Maria Chimalhuacan 3
Skopje 3
Taizhou 3
Zhengzhou 3
Zurich 3
Adrara San Martino 2
Amsterdam 2
Aprilia 2
Borås 2
Chengdu 2
Chiswick 2
Delhi 2
Duncan 2
Formello 2
Frankfurt am Main 2
Fuzhou 2
Gangseo-gu 2
Genoa 2
Gent 2
Gwangmyeong 2
Jiaxing 2
Kafr ash Shaykh 2
Kaohsiung City 2
Kharkiv 2
Nakhon Ratchasima 2
Norwalk 2
Orange 2
Osio Sopra 2
Ottawa 2
Parma 2
Pisa 2
Qingdao 2
Rovigo 2
Totale 3.303
Salva come PNG Salva come JPEG
Nome #
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 169
Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes 164
NETosis is induced by high glucose and associated with type 2 diabetes. 151
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial 147
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 141
DPP-4 inhibitors moderate the risk of genitourinary tract infections associated with SGLT2 inhibitors 134
The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo 124
Acute effects of linagliptin on progenitor cells, monocyte phenotypes, and soluble mediators in type 2 diabetes 118
SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System 116
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 112
Synergistic Interactions Among Metabolic Syndrome Components and Homeostasis Model Assessment of Insulin Resistance in a Middle-Aged General Population over Time. 105
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study 99
Angiogenic Abnormalities in Diabetes Mellitus: Mechanistic and Clinical Aspects 97
Tocilizumab for severe COVID-19 pneumonia 96
Subclinical Hypothyroidism and Metabolic Syndrome: A Common Association by Chance or a Cardiovascular Risk Driver? 93
Circulating Stem Cells Associate With Adiposity and Future Metabolic Deterioration in Healthy Subjects 92
DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes 92
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration 92
Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine care 92
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: A randomized placebo-controlled trial 91
Shift of monocyte subsets along their continuum predicts cardiovascular outcomes 86
Exposure to dipeptidyl-peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta-analysis 82
p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications 81
Effects of SGLT2 inhibitors on circulating stem and progenitor cells in patients with type 2 diabetes 77
Effects of exenatide long-acting release on cardiovascular events and mortality in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials 76
Effects of Age, Diabetes, and Vascular Disease on Growth Differentiation Factor 11: First-in-Human Study 75
Hematopoietic and Nonhematopoietic p66Shc Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes 73
Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature 72
Effects of Hypoglycemia on Circulating Stem and Progenitor Cells in Diabetic Patients 69
Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes 67
Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trial 67
Exposure to insulin degludec during pregnancy: report of a small series and review of the literature 66
Diabetes mellitus impairs circulating proangiogenic granulocytes 61
Circulating stem cells and cardiovascular outcomes: from basic science to the clinic 60
Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy 57
Effects of glucose variability on hematopoietic stem/progenitor cells in patients with type 1 diabetes 55
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial 55
Comparative effectiveness of exenatide once-weekly versus liraglutide in routine clinical practice: A retrospective multicentre study and meta-analysis of observational studies 54
Diabetes pharmacotherapy and circulating stem/progenitor cells. State of the art and evidence gaps 46
Extraglycemic effects of SGLT2 inhibitors: A review of the evidence 45
Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19 44
Euglycemic Ketoacidosis 43
Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis 41
The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy 38
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care 28
Glycaemic Control Achieves Sustained Increases of Circulating Endothelial Progenitor Cells in Patients Hospitalized for Decompensated Diabetes: An Observational Study 28
SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system 27
Why diabetes outpatient clinics should not close during pandemic crises 25
Outcomes of patients with type 2 diabetes treated with SGLT-2 inhibitors versus DPP-4 inhibitors. An Italian real-world study in the context of other observational studies 19
Hematopoietic progenitor cell liabilities and alarmins S100A8/A9-related inflammaging associate with frailty and predict poor cardiovascular outcomes in older adults 19
Managing diabetes in diabetic patients with COVID: where do we start from? 18
Putative circulating adipose tissue-derived stem cells, obesity, and metabolic syndrome features 17
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study 17
Ketosis-prone Diabetes and Hypogonadism: A New Clinical Association to be Aware of ? 12
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells 11
Circulating haematopoietic stem cells and long-term outcomes of COVID-19 10
Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review 6
Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysis 5
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus 2
Totale 4.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.860
article - articoli 18.860
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.720
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020358 0 0 0 0 0 0 96 61 66 44 62 29
2020/2021912 41 48 68 79 54 35 19 64 84 238 90 92
2021/2022789 43 72 78 52 85 55 31 64 71 20 40 178
2022/2023590 127 79 15 67 73 70 5 55 53 12 32 2
2023/2024340 9 43 41 26 13 59 25 19 31 14 28 32
2024/2025446 3 99 49 56 158 62 19 0 0 0 0 0
Totale 4.059